Kalos Therapeutics Company
Kalos Therapeutics develops atrial natriuretic peptides for the treatment of cancer.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Founded Date:
2005
Employees Number:
1-10
Estimated Revenue:
Less than $1M
Register and Claim Ownership